PD-L1 assessment in cytology samples predicts treatment response to checkpoint inhibitors in NSCLC. Lau SCM, Rabindranath M, Weiss J, Li JJN, et al. Lung Cancer 2022;171:42-46.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lau SCM, Rabindranath M, Weiss J, Li JJN, et al. PD-L1 assessment in cytology samples predicts treatment response to checkpoint inhibitors in NSCLC. Lung Cancer 2022;171:42-46.
PMID: 35907387